Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Board of Directors Read more about Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Board of Directors
Celgene and Agios Extend Cancer Metabolism Collaboration Read more about Celgene and Agios Extend Cancer Metabolism Collaboration
Celebrating 16 Years of Cancer Support at Gilda's Club NYC Read more about Celebrating 16 Years of Cancer Support at Gilda's Club NYC
Agios Secures $78 Million in Oversubscribed Series C Financing Read more about Agios Secures $78 Million in Oversubscribed Series C Financing
Agios Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference Read more about Agios Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
Agios Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference Read more about Agios Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
Agios Research in Cancer Metabolism Highlighted at AACR Annual Meeting 2012 Read more about Agios Research in Cancer Metabolism Highlighted at AACR Annual Meeting 2012
Agios Strengthens Team with Key Appointments and Promotion Read more about Agios Strengthens Team with Key Appointments and Promotion
Agios Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference Read more about Agios Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
BIO Welcomes David Schenkein, M.D., to the Emerging Companies Section Governing Board Read more about BIO Welcomes David Schenkein, M.D., to the Emerging Companies Section Governing Board